These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6126417)

  • 61. Propranolol effect on portal hypertension.
    Ozsoylu S
    Hepatology; 1988; 8(3):707. PubMed ID: 3371890
    [No Abstract]   [Full Text] [Related]  

  • 62. Treatment options in portal hypertension: Does propranolol have a role? Proceedings of a satellite symposium of the XIII International Congress of Gastroenterology and the VI European Congress of Digestive Endoscopy. Rome, 9 September 1988.
    Drugs; 1989; 37 Suppl 2():1-73. PubMed ID: 2806132
    [No Abstract]   [Full Text] [Related]  

  • 63. [Indications for surgical treatment of portal hypertension caused by alcoholic cirrhosis].
    Visset J
    Arch Fr Mal App Dig; 1966 Sep; 55(9):825. PubMed ID: 5981230
    [No Abstract]   [Full Text] [Related]  

  • 64. Important details to be clarified about the effect of rectal ozone on the portal vein oxygenation.
    Bocci V; Zanardi I; Travagli V
    Br J Clin Pharmacol; 2011 Aug; 72(2):350-1; author reply 352. PubMed ID: 21446933
    [No Abstract]   [Full Text] [Related]  

  • 65. Breaking bad - the two sides of gut microbiota in portal hypertension.
    Mehta G; Mookerjee RP
    Liver Int; 2014 Oct; 34(9):1295-7. PubMed ID: 24840789
    [No Abstract]   [Full Text] [Related]  

  • 66. [Medical therapy of portal hypertension].
    Baldassarre G; Ventrella F; Gadaleta CD
    Clin Ter; 1986 May; 117(4):355-60. PubMed ID: 3731740
    [No Abstract]   [Full Text] [Related]  

  • 67. Additive effect of intravenous and intrasplenic pituitrin in portal hypertension.
    Shah CP; Shah SN; Shah BR; Sanghavi NG
    J Assoc Physicians India; 1969 Jun; 17(6):359-62. PubMed ID: 5347672
    [No Abstract]   [Full Text] [Related]  

  • 68. Safety of propranolol in portal hypertension. Conventional and long acting formulations.
    Hayes PC
    Drugs; 1989; 37 Suppl 2():70-3; discussion 74-6. PubMed ID: 2680433
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The current trends in the drug treatment of portal hypertension].
    Kolarski V; Nikolov S
    Vutr Boles; 1990; 29(3):8-13. PubMed ID: 2284805
    [No Abstract]   [Full Text] [Related]  

  • 70. [Use of levamisole in liver cirrhosis].
    Patsiora MD; Glezer GA; Ershov IuA; Rachkov SM; Morozov VA
    Klin Khir (1962); 1981 Mar; (3):19-21. PubMed ID: 6971365
    [No Abstract]   [Full Text] [Related]  

  • 71. [Physiopathology of the hepato-renal syndrome. Effects on renal function induced by infusion of pitressin in the mesenteric artery of the dog during portal hypertension].
    Bazzato G; Gordon SJ; Onesti G; Kowlessar OD
    Minerva Nefrol; 1975; 22(6):281-90. PubMed ID: 1223706
    [No Abstract]   [Full Text] [Related]  

  • 72. Propranolol for portal hypertension.
    Dominguez P
    Lancet; 1981 Jun; 1(8233):1322-3. PubMed ID: 6112641
    [No Abstract]   [Full Text] [Related]  

  • 73. [Reduction of portal stasis in liver cirrhosis by some medicinal preparations].
    Mansurov KhKh; Nikolaeva OS
    Klin Med (Mosk); 1971 Feb; 49(2):67-72. PubMed ID: 5120753
    [No Abstract]   [Full Text] [Related]  

  • 74. Medical treatment of portal hypertension and oesophageal varices.
    Cales P; Braillon A; Lebrec D
    Br Med J (Clin Res Ed); 1983 Oct; 287(6399):1144. PubMed ID: 6414607
    [No Abstract]   [Full Text] [Related]  

  • 75. Propranolol improves endothelial dysfunction in advanced cirrhosis: the 'endothelial exhaustion' hypothesis.
    Brito-Azevedo A; Perez Rde M; Coelho HS; Fernandes Ede S; Castiglione RC; Villela-Nogueira CA; Bouskela E
    Gut; 2016 Aug; 65(8):1391-2. PubMed ID: 26984854
    [No Abstract]   [Full Text] [Related]  

  • 76. [Absorption of oral digoxin in liver cirrhosis].
    Somogyi G; Földvári A; Ibrányi E; Kiss E
    Orv Hetil; 1975 Jan; 116(2):84. PubMed ID: 1109484
    [No Abstract]   [Full Text] [Related]  

  • 77. [Neurotransmitters, hormones and portal hypertension].
    Li XN; Huang CT
    Zhonghua Wai Ke Za Zhi; 1988 Jun; 26(6):377-80. PubMed ID: 2906583
    [No Abstract]   [Full Text] [Related]  

  • 78. [A case of insipid pitressin-resistant polyuria in an edematous cirrhotic. Physiopathologic bases of polyuria of hydropigenous cirrhotics].
    Plauchu M; Berger G; Dazord A
    Lyon Med; 1969 Mar; 221(9):437-42. PubMed ID: 5360532
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacological management of portal hypertension: current status and future.
    Gao ZQ; Han Y; Li L; Ding HG
    Chin Med J (Engl); 2020 Oct; 133(19):2362-2364. PubMed ID: 32925278
    [No Abstract]   [Full Text] [Related]  

  • 80. Editorial: metformin for portal hypertension-old dog, new tricks? Authors' reply.
    Rittig N; Aagaard NK; Villadsen GE; Sandahl TD; Jessen N; Grønbaek H; George J
    Aliment Pharmacol Ther; 2021 Aug; 54(3):347. PubMed ID: 34236099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.